Cresud S.A.C.I.F. y A. (NASDAQ:CRESY – Get Free Report) and Moolec Science (NASDAQ:MLEC – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.
Profitability
This table compares Cresud S.A.C.I.F. y A. and Moolec Science’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cresud S.A.C.I.F. y A. | 10.57% | 4.65% | 1.99% |
| Moolec Science | N/A | N/A | N/A |
Volatility and Risk
Cresud S.A.C.I.F. y A. has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Moolec Science has a beta of -0.53, meaning that its share price is 153% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cresud S.A.C.I.F. y A. | 0 | 1 | 0 | 0 | 2.00 |
| Moolec Science | 0 | 0 | 0 | 0 | 0.00 |
Insider and Institutional Ownership
12.9% of Cresud S.A.C.I.F. y A. shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 36.2% of Cresud S.A.C.I.F. y A. shares are owned by company insiders. Comparatively, 19.9% of Moolec Science shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Cresud S.A.C.I.F. y A. and Moolec Science”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cresud S.A.C.I.F. y A. | $914.16 billion | 0.00 | $96.15 million | $1.15 | 10.36 |
| Moolec Science | $5.62 million | 0.44 | -$7.31 million | ($2.20) | -0.28 |
Cresud S.A.C.I.F. y A. has higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Cresud S.A.C.I.F. y A., indicating that it is currently the more affordable of the two stocks.
Summary
Cresud S.A.C.I.F. y A. beats Moolec Science on 11 of the 12 factors compared between the two stocks.
About Cresud S.A.C.I.F. y A.
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, engages in the production of agricultural commodities in Brazil and other Latin American countries. The company operates through Agricultural Business, and Business Urban Properties and Investments segments. It is also involved in the management, development, and ownership of shopping malls, office buildings, and hotels; sale of grain derivatives, such as flour and oil; production and sale of crops, such as soybean, sugarcane, wheat, corn, oilseed, and sunflower, as well as sorghum and peanuts; and breeding, purchasing, and/or fattening of cattle for sale to slaughterhouses and supermarkets. In addition, it leases its farms to third parties for agriculture, cattle breeding, and seed production; and offers agricultural services. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Receive News & Ratings for Cresud S.A.C.I.F. y A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresud S.A.C.I.F. y A. and related companies with MarketBeat.com's FREE daily email newsletter.
